Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia climbs as lung disorder drug shows efficacy

** Shares of Amplia Therapeutics  ATX.AX  rise as much as
18.2% to A$0.13, their best intraday session since Dec. 21
    ** Says data from a preclinical study showed that its
molecularly targeted drug, AMP945, showed efficacy while being
tested as a therapy for a type of lung fibrosis  urn:newsml:reuters.com:*:nASX9yQ3pZ 
    ** Stock hits highest level since May 23 
    ** ATX down by a third YTD, as of last close     

 (Reporting by Harshita Swaminathan)
 ((Harshita.Swaminathan@thomsonreuters.com))

Recent news on Amplia Therapeutics

See all news